Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype.

Clinical neurology and neurosurgery - 1 May 2023

Kim Min Joo, Park Jae-Sung, Jeun Sin-Soo, Ahn Stephen

Abstract excerpt

BACKGROUND: The prognostic significance of the presence of cystic features in patients with newly diagnosed glioblastoma (GB) is highly controversial. The purpose of this study was to determine whether cystic GB patients have a more favorable prognosis compared to non-cystic GB patients. METHODS: The records of all GB patients diagnosed between August 2008 and December 2020 at Seoul St. Mary's Hospital were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioblastoma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 37043844
DOI: 10.1016/j.clineuro.2023.107708

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype.PMID 37043844Read ↗

Cystic glioblastoma: an evaluation of IDH1 status and prognosis.Semantic proximity Read ↗

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.Semantic proximity Read ↗

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsSemantic proximity Read ↗

A prognostic model of newly diagnosed glioblastoma based on clinical characteristicsSemantic proximity Read ↗

Glioblastoma: Changing concepts in the WHO CNS5 classification.Semantic proximity Read ↗

Distinguishing IDH-mutant astrocytomas from IDH-wildtype glioblastomas using qualitative and quantitative MRI features: a WHO CNS5 study.Semantic proximity Read ↗

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.Semantic proximity Read ↗

Updates in IDH-Wildtype Glioblastoma.Semantic proximity Read ↗

Molecular features of intratumoral hemorrhage in glioblastoma isocitrate dehydrogenase-wildtype.Semantic proximity Read ↗

Molecularly diagnosed glioblastoma: clinical presentation and outcomes.Semantic proximity Read ↗

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Semantic proximity Read ↗

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.